GL1X · GenesisL1 explorer

Research workbench

Crystal structure of two covalent nucleoside derivatives of ribonuclease a

Analyse Crystal structure of two covalent nucleoside derivatives of ribonuclease a in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
9RSA
Type
protein
Length
248 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribonuclease a
EC
3.1.27.5
UniProt
P61823
Ligands
ADU
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 21% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRibonuclease a (EC 3.1.27.5)protein12421% helix, 36% strandP61823

Ligands and binding sites

  • ADU · 3'-deoxy-3'-acetamido-uridine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13480.630.7947empty

Interfaces

1 interface between chains.

  • A–B · 953 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 2 covalent (disulfide, covalent ligand).

Compared structures

  • 9RSA · Crystal structure of two covalent nucleoside derivatives of ribonuclease a · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.